{"cmr":"kr-cm-kg/KOSDAQ/000250","since":null,"total":56,"cursor":0,"limit":50,"next_cursor":50,"events":[{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-11-02","event_type":"corporate_news","title":"투자판단관련주요경영사항              (황반변성치료제(주성분: Aflibercept) 바이오시밀러 SCD411의 일본 독점판매권 및 공급계약 체결)","reference":"20261102900634","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261102900634","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"T5-DGwBSKKZagYfbHH1zHuya6zk4YaNSume6d4HMtjbJAfte8bgHMExQU-bdcgQ6QLO4npIv3YWVB89HZRhzDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-11-02","event_type":"corporate_news","title":"투자판단관련주요경영사항              (황반변성치료제(주성분: Aflibercept) 바이오시밀러 SCD411의 일본 독점판매권 및 공급계약 해지)","reference":"20261102900593","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261102900593","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"N8OJ3QnFyMCWE1zbADbIM3r02v_hlmCT6bB0PJtNXOT08CVdYnqYncX7l1Fz0eXVh2i1YRE0LU8dDg0Yg9hSAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-10-20","event_type":"major_holder","title":"주식등의대량보유상황보고서(일반)","reference":"20261020000330","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261020000330","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 윤대인; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"STX5a3bgBzHCNr8mmPdDycO4CzgNkeX2ds1ddCUtsRXHBr2hv_lU6F5bUoKIY3o7Gq8DgtZOMXBhV2ZeKRqKAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-10-08","event_type":"results","title":"[기재정정]반기보고서 (2026.06)","reference":"20261008000530","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000530","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Lr6sC1UiB7IhydpZBvPq5V0eZEBOhy6nBHOm8MEGWaaB_9KZnNZ3Z6yZissIUxNVAoHr3rmqmQC5GeOu02qDCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-10-08","event_type":"results","title":"[기재정정]분기보고서 (2026.03)","reference":"20261008000520","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20261008000520","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HAUC4M0fSz61pG2O9x-DXb9_D6NAEFA0VfUxdmVoO9lZDwnOLdTQttYGO1NPDZRq_C0xuKAvG9GuOygbm8rHCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-08-14","event_type":"major_holder","title":"주식등의대량보유상황보고서(일반)","reference":"20260814003962","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814003962","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 윤대인; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"T-IiEx45wROqwgdgEu-Z4v9r-h-kjr1mE-Y2Mv-Jh8RgDxqHm-BWmsNKzW1M7atZP4e3FEppmMbhyGEHLPHgCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-08-14","event_type":"results","title":"반기보고서 (2026.06)","reference":"20260814003598","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260814003598","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rLQmJplo90_dwMEsXe0hKOV1NyNMFw8mc6dhKLxsYigZrJbmX2EQ5_B7ZwD1Z15tmGHjwxBxHOGtfnSa0w4hBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-08-05","event_type":"corporate_news","title":"[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정)              (제1형 당뇨병 환자를 대상으로 정상혈당 클램프 조건 및 식이 섭취 후, 경구용 인슐린 SCD0503과 피하 투여 인슐린 간의 상대적 생체이용률, 상대적 생물학적 효력 및 음식 영향 평가를 위한 임상시험)","reference":"20260805900726","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260805900726","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"97jTMpBP4y6Q0ljBi-mUA0h-zPg8USnv1IHnZx4Td1sYEudIeIgDSXmrS2gTtTAYHcdlh-FTxZP16iN8a_2PAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-08-05","event_type":"corporate_news","title":"[기재정정]투자판단관련주요경영사항(임상시험계획승인신청)              (제1형 당뇨병 환자를 대상으로 정상혈당 클램프 조건 및 식이 섭취 후, 경구용 인슐린 SCD0503과 피하 투여 인슐린 간의 상대적 생체이용률, 상대적 생물학적 효력 및 음식 영향 평가를 위한 임상시험)","reference":"20260805900724","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260805900724","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qxMeRRhMaSp2VAlLuLV4Vj1Ntfi4ogyBdUDBBEPXTxJ8mTj__Acn0p3Dv_QcSr04Gt_Yw9A49NDhxK886a92AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-07-23","event_type":"major_holder","title":"주식등의대량보유상황보고서(일반)","reference":"20260723000516","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260723000516","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 윤대인; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uSqzK9mqhP8CaYhlYavM_Fy7UrK8i8dR-s5Z2vThsi16ECnpjSpX1S5RpdY0ZqqHHqjcHiP81wtl_6IjJfzGBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-06-30","event_type":"agm_egm","title":"임시주주총회결과","reference":"20260630900462","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260630900462","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"oyVHSShM33An7JLa7_gs70lwNpTuainnwVzFNVFfrPo8bDYtIcyoCXFIrHfdVqpXH9u9KCIta_8_ZdIP7_d1AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-06-30","event_type":"corporate_news","title":"독립이사의선임ㆍ해임또는중도퇴임에관한신고","reference":"20260630000453","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260630000453","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"woFxJN4-eONyChqnsxKfht2Uq3VnyKSTGG8AUXGWC1pvGn3R7-CvuDspZE83t3dVvD7QoERusKvDooH9wTX9CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-06-12","event_type":"agm_egm","title":"주주총회소집공고","reference":"20260612000460","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260612000460","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PxrsNHuU_kKlieqlYRzAfcfIGAtZ6H7U7pEnQXskarFzemFiHzfi5eWREe7IArF04gqvI61Xwvu5wf9ZAaBZAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-06-10","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260610900124","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260610900124","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"quYjZBgxSdTkE1iPvA4XfGDVWPnb2d-9p_4z9-XGXHVYq7SeEFdzaS5O-oAk3q4Qg9-KaOTX1lNcq4MWilyvBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-06-04","event_type":"results","title":"[기재정정]사업보고서 (2025.12)","reference":"20260602000573","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260602000573","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 연","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"J62L_6BGDFBrp8na43ypqk_WU31M0f5m_antufcvHctoakldufpZYO5KAmqpZmmIaF9LaNqvDCWT8Xeu8bihDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-05-29","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획승인신청등결정)              (제1형 당뇨병 환자를 대상으로 정상혈당 클램프 조건 및 식이 섭취 후, 경구용 인슐린 SCD0503과 피하 투여 인슐린 간의 상대적 생체이용률, 상대적 생물학적 효력 및 음식 영향 평가를 위한 임상시험)","reference":"20260529900029","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260529900029","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cUB-9OSbj6obawbmZD1_SO13nlZopbI09EWtgtQBh3CKNrN_eCorEaeBDpTHK5ZahjoiWPUXogdHYOMIuqSVCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-05-15","event_type":"results","title":"분기보고서 (2026.03)","reference":"20260515002084","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260515002084","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ku3d3vagC4850bzFawuM99S-CNjpIS1X4s-9nM0zk0fyMKYQsrtUgA046Cj_KTfQVocSdEl5Eti8YxloZ_xjCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-27","event_type":"agm_egm","title":"주주총회소집결의              (임시주주총회)","reference":"20260427900263","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260427900263","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yZ2LiXBykiGnV2fxW8OT47HHxlasA468B7MQBq-SaJdcqeTJKBY43C425Gv-FZ85zOUCcjta1OwACbV1SpmWAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-27","event_type":"corporate_news","title":"주주명부폐쇄기간또는기준일설정","reference":"20260427900267","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260427900267","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g4HZk80Q2wfX-rTFLTsSy9oCunUY6qq7d2MXFnComkK1ncHGgg-1AQ_Of5eFqZwxj80jFKHqRhwILS8wcvgfCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-27","event_type":"corporate_news","title":"독립이사의선임ㆍ해임또는중도퇴임에관한신고","reference":"20260427000200","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260427000200","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uEEB1c882CiNMN8pSO50W5b9lX4RFQQRFfBhUMIdZwVAyRXN-znN5iFahoToqE37MWsavtctaMx7xVWRYJrBDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-20","event_type":"corporate_news","title":"불성실공시법인지정              (공시불이행)","reference":"20260420900903","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260420900903","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 코스닥시장본부; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fD0rK9v-Fr6okYwnGW1GhI2gg6NnXCk1iJ6vUkAFhNtXSLd6vWxlhoTRKkV5giMEBtCCS7rp6oDJLCyIEMxzDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-16","event_type":"corporate_news","title":"[기재정정]기업설명회(IR)개최","reference":"20260416900415","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260416900415","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Y3VIIq86PIz1P0fiiQylqY8ImXRd9aUsc66F1lIVcsYfjpenQedAmYglqc0x8jior7qaa-xuL2NGHq-ZjUUzBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-04-06","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등거래계획철회보고서","reference":"20260406000022","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260406000022","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 전인석; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CiPk1QQc_JWVRQj48_DUo6psXigOHtFLlPAx1ZwZf0Ca4UJzrnaa2kd99u8q0mx4j78ZdV0FFmm_d7v1ofPIDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-31","event_type":"corporate_news","title":"불성실공시법인지정예고              (공시불이행)","reference":"20260331904755","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260331904755","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 코스닥시장본부; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-PqjbKZT0zBn8NNffFhsjhnbyo5z7rLugRBXKiR9MDEaF6osPP0ZOfNJiNQNU603pjGY9uy6fnlqNmswCJ48Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-30","event_type":"agm_egm","title":"정기주주총회결과","reference":"20260330901934","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260330901934","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"djB954cU-PclJ1qd9n5lFxNQjieQv87Ot0FZgMJ5o5YdMGbRCaMIOnRZ81YTh15AH6GaJPYXyWmMG3BXqbJQAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-30","event_type":"corporate_news","title":"독립이사의선임ㆍ해임또는중도퇴임에관한신고","reference":"20260330001806","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260330001806","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ytjVTkq2_Wk_d6URUYVJbKoDh7e3UlSW344HKzufsBwIA9qoZcwDNJmiIO4PvrdKBnfznKYiiK_BzU18WrEPCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-30","event_type":"corporate_news","title":"투자판단관련주요경영사항              (경구용 당뇨 치료제 리벨서스 제네릭 및 경구용 비만 치료제 위고비 오럴 제네릭(세마글루타이드) 미국 라이센스 계약 체결)","reference":"20260330901302","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260330901302","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"o6zYBo166yMRDLfs3XFEO4gdPjQNrsKyo9nMm1A2vVVdjgEbqPDc2NTiaBv5QwLYgHo_PTHLkBIyp8Ul0gmkDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-24","event_type":"directors_dealings","title":"임원ㆍ주요주주특정증권등거래계획보고서","reference":"20260324000967","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260324000967","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 전인석; corp_cls K; remarks 철","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zssBd1vJyIbeqJDNPpqj8x5Qq9bM93BhFko2btMts0UqQW9EEiubf9RxBYzFDS5JQVRXLt0Z-JeTMEvo6eyiCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-20","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20260320900145","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320900145","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qoGXonNrdvcVFotipyp2oGrKYcyQJWxUy5NZAg4sPwwW3qFqjeU99piD5IttJY6ql0XXdWvFkHwjisvhdPXVCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-20","event_type":"regulatory_filing","title":"감사보고서제출","reference":"20260320901132","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320901132","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"T4a6ouq8kq3k2oRSGcispG_ipM6gEzTR72CaUFBXCYc4gRQ0ZfqITQj0mqKZhTNXgO_JmrLDBEMEdknxdTd1Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-20","event_type":"results","title":"사업보고서 (2025.12)","reference":"20260320001096","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001096","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 정연","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3r4iewQXjeYTs4F_s06VCMwI3vjSgDP0vrNZOS6XYVqIYKAEUWVE_nQ9B5jLekMBIkWUE7t92t2NzUy7r3VQDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-19","event_type":"corporate_news","title":"투자판단관련주요경영사항(임상시험계획승인신청)              (제1형 당뇨병 환자를 대상으로 정상혈당 클램프 조건 및 식이 섭취 후, 경구용 인슐린 SCD0503과 피하 투여 인슐린 간의 상대적 생체이용률, 상대적 생물학적 효력 및 음식 영향 평가를 위한 임상시험)","reference":"20260319900372","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260319900372","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jPy6CwiDFMP_tXGul6x0VIZWnZqZKQDbiRPNiSuIdnaO87lU6TJU7csWgoi-bj8ZadERBwz4Ne5nbWzKNjW1Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-10","event_type":"agm_egm","title":"주주총회소집공고","reference":"20260310002732","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260310002732","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rs2auyhY7KfVAUX6uaoCwqV2bX7XUk2zJAJpRvsDyypCK_8awKHRtW8Eyg_ALpi7VJRhY3U7r3NQhHUn-g--Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-03","event_type":"agm_egm","title":"주주총회집중일개최사유신고","reference":"20260303900854","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260303900854","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AmJG6lcMmT1OJUDLLNGznWFomBV11DwzG8kwbNzgZKWbPz3HtXDFfeXtSLjSg3xy6tUvtePKF1DARDMnj-I1AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-03-03","event_type":"agm_egm","title":"주주총회소집결의","reference":"20260303900851","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260303900851","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Wl8wT2Kvg0jQ8LFUvghxvCfPNEa3OP0Xls-5tOjGxvWxtrghmKDM9XwJ0Hho9kE9vhdmPpQEmfB41UaW3kzdDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-02-26","event_type":"corporate_news","title":"투자판단관련주요경영사항              (경구용 당뇨 치료제 리벨서스 제네릭 및 경구용 비만 치료제 위고비 오럴 제네릭(세마글루타이드) 영국 외 유럽 10개 국가 독점 라이센스 및 상업화 계약 체결)","reference":"20260226900187","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260226900187","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"PVhSdMGDDWaNwOOIbXVcp4rPju9-zj19kcK8rk9AHsjnAP_GhZnqgXbXkPpZYxm3OTx26rQ2SZOx4He5v1VXCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-02-19","event_type":"corporate_news","title":"[기재정정]투자판단관련주요경영사항              (황반변성치료제(아일리아/주성분 : Aflibercept) 바이오시밀러 SCD411(Vial&PFS)의 캐나다 독점판매권 공급계약 체결 및 중동 6개 국가 추가 계약 체결)","reference":"20260219900223","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260219900223","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"OC-x-ytAdrAR4H1M5vDF4JsV7qTdJkAixLrKuP985lNh3Oo82k-A3a8B2Q-2LBZFBxlsNf5zrCYQsE-c8pZXDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-02-10","event_type":"dividend","title":"현금ㆍ현물배당결정","reference":"20260210900408","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260210900408","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"QJyT15fJiwcJIsLdp8B0HqIdZ75AHK-iMnqmnziPf3lEpx-I80WPmHtMRkL9vpEofWPI6Wv90hiDJ01aJjuXDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-02-10","event_type":"results","title":"매출액또는손익구조30%(대규모법인은15%)이상변동","reference":"20260210900381","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260210900381","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iPx8hrMVNoQIG29UY_owGOtia5M_l6CpANzElqrhx6xXoVSv3eKoDPvwXCyyLEr1hB6gVqlCTtEnJxbVsmegAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2026-01-22","event_type":"exchange_bulletin","title":"수시공시의무관련사항(공정공시)              (일본 판매용 경구용 세마글루타이드 공동개발 및 상업화 파트너십 계약 체결)","reference":"20260122900301","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260122900301","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6fKeV3Nx6bcijzODnRFjO-PRwfRJ0goUwS-ijUDixbqw4kbrsFakV-ClF0HqhHgJxkec3xXhcwrs2C1pmEC7Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-12-29","event_type":"corporate_news","title":"[기재정정]단일판매ㆍ공급계약체결(자율공시)","reference":"20251229900487","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251229900487","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"W21IIoR43sIi2CP63yrDc86tkFJr7Dg0bfWpUYBqKwS8TpJlcjiyJoHBhK-rTukGCxF8nW7fwBVJSVyfsGemBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-12-24","event_type":"corporate_news","title":"[기재정정]단일판매ㆍ공급계약체결(자율공시)","reference":"20251224900303","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251224900303","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gM57JSUZX7v_CyHrcX5z8E-olRCE7R41K_B-MVVOS-3_czKrenjaEKpYiuytws0lvSYMkxCo3obl6lPO5COoBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-12-16","event_type":"corporate_news","title":"주주명부폐쇄기간또는기준일설정","reference":"20251216900080","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251216900080","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nvzSHUvGtwf2NDtIXcocopyuwd87M3SdoeYeHEQTMgmiXm4uWQpGsGS3VbXDB_7gq2GVQ0yCdP_ngAFQQ0CgAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-12-16","event_type":"dividend","title":"현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정","reference":"20251216900073","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251216900073","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pNb--qxtjDDQRemMiNZs-5EbeRFFd_eKJIC9XbAb_HYkcrGsYXMyxF76R7EjPsxj3vkwzHlxxpzohd_kQf3RAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-12-09","event_type":"corporate_news","title":"기업설명회(IR)개최","reference":"20251209900053","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251209900053","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lHbTG3PhJn6o8MzSPb8mo_Upm22q9AM8TxLR7JCZPh5w6sVRtckWo0vHnrJorQgkvxntHnax5ag3ftcvInAeCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-11-28","event_type":"corporate_news","title":"[기재정정]단일판매ㆍ공급계약체결(자율공시)","reference":"20251128900777","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251128900777","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코정","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"m_PNYcQnhkaikdJ6hVohkntMEiq-j2i0Tr2hk1qZQfGAaWjfv0FVChNiyuNHSOs9Ylv6jM5xxHNUbkVdcSnvDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-11-14","event_type":"results","title":"분기보고서 (2025.09)","reference":"20251114001763","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251114001763","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2MGEC6IHc4HdY3u5wbaTlZ1nctfL6AeowgHdEl2MVvmAczhcvreH3yVHxbKVxxel10OpSbtFFLamY00M1j3gCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-11-12","event_type":"corporate_news","title":"[기재정정]투자판단관련주요경영사항              (황반변성치료제(아일리아/주성분 : Aflibercept) 바이오시밀러 SCD411 2mg 저용량(Vial&PFS) 및 8mg 고용량(Vial&PFS)의 미국 및 라틴아메리카 6개국 독점 공급 및 판매계약 체결)","reference":"20251112900001","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251112900001","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"j4TpQvOCGckuD6M9olPzWu-c_JAGTSI9m8tM3zANx82ZWy9gnC-FJdvpZeSI90v_aPv5vJWVDMNWNOFqbH5VCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-10-24","event_type":"major_holder","title":"주식등의대량보유상황보고서(일반)","reference":"20251024000379","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251024000379","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 윤대인; corp_cls K; remarks ","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Rn2y2ZU3ki6PFSlaMiU5hxeJs5pZwG4_7hV_tbcGNILVS2vQaK9PuDBflAK72G3sZn7FMZaHImV_SBrKZNKIAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"kr-cm-kg/KOSDAQ/000250","date":"2025-10-22","event_type":"corporate_news","title":"타법인주식및출자증권취득결정(자율공시)","reference":"20251022900320","language":"ko","wire":"DART","source":"DART (전자공시시스템) — filing","url":"https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20251022900320","read_by":"DART list API (filings per corp_code)","detail":"pblntf_ty  ; submitter 삼천당제약; corp_cls K; remarks 코","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xgG_92kUVmwn7hjd0Pa9KIzZSueCkz7Pl8X7aZRC2LM9tDFab47hX3YTpRKT3JPZxWet7a_bmFpbKY0xHfUQDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}